A research team at the University of Virginia Health has made an exciting discovery that could lead to new treatments for ...

Know crucial difference and best treatment option that could save your life Here are a few prevention tips to keep in mind: ...

Heart disease patients now have another treatment option. The U.S. Food and Drug Administration has approved Alnylam ...

Multivariable risk assessment can be used to effectively target intervention to those at significant for an initial CHD event and to avoid over-treatment. It is important to appreciate that the ...

Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ...

The company expects next quarter to read out initial data from its Heart-2 trial, which is testing a one-time treatment for ...

The risk of dying from heart complications is significantly higher in the first 2 years after a colorectal cancer diagnosis, ...

Johnson & Johnson MedTech, the global leader in heart recovery, will feature the latest evidence demonstrating the survival benefit of Impella® heart pump technology at the American College of ...

Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...

HIGH POINT, N.C. (WGHP) — Around 18 million Americans are living with heart disease and the treatment is constantly evolving. Dr. Thomas Stuckey is the medical director of the LeBauer-Brodie ...

Black and Hispanic individuals experience higher rates of heart disease and often face barriers to early diagnosis and treatment. By promoting educational initiatives and making AEDs more ...